Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

1(20.0%)

Phase 3

1(20.0%)

5Total

N/A(3)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07354672Recruiting

Pathogen-Reduced Platelet Concentrates: Experience in Routine Practice in Germany

Role: lead

NCT05271929Phase 3Terminated

Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19

Role: lead

NCT04433910Phase 2Completed

A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19

Role: lead

NCT02552719Completed

Validation of the German Version of the Injustice Experience Questionnaire

Role: collaborator

NCT02820675Not ApplicableCompleted

Quality Improvement in Infection COntrol and Sepsis Management in MOdel Regions

Role: collaborator

NCT03561909Not ApplicableCompleted

Kinetics of Blood Platelets Transfused to Healthy Subjects

Role: collaborator

NCT00792220Not ApplicableCompleted

"Mobile Stroke-Unit" for Reduction of the Response Time in Ischemic Stroke

Role: collaborator

All 7 trials loaded